Group Underlying Profit Growth
Underlying EBIT up 7.3% and underlying NPAT up 8.1% for the half, driven primarily by Australian operations and higher acuity across regions.
Strong Australian Revenue and Admissions
Revenue from customers in Australia increased 8.2%; revenue from the private hospital portfolio grew 8.7%. Hospital admissions rose 3.1% and core surgical admissions grew 5.7%, with higher-acuity case mix (IPDAs growing faster than admissions).
Margin and Utilization Improvements in Australia
EBIT margins (excluding Joondalup) improved by 40 basis points versus prior period; 12-month rolling theatre utilization increased ~1.3% despite new capacity additions.
Cashflow and Balance Sheet Improvements
Operating cash flow improved 16.9% to $350 million; Funding Group leverage (ex-Santé) is 2.22x, within target (<2.5x); weighted average cost of debt declined ~20 bps since 30 June 2025 following refinancing (syndicated facility margin down 30 bps).
Dividend and Capital Allocation Discipline
Board declared a fully franked interim dividend of $0.425 per share (+6.3%); payout ratio 60% of underlying earnings, and Group CapEx guidance reduced (now $755m–$795m) reflecting disciplined capital allocation.
Development and Capacity Additions
23 new theatres/procedure rooms scheduled to open in FY26 (major hospitals / key catchments); Australian development CapEx now expected $170m–$190m (below prior guidance) as projects are reprioritised and utilization optimized.
Operational and Clinical Initiatives
Multiyear transformation progress: improved patient/doctor/people NPS, 23% growth in clinical trials activity, targeted 'Big 5' hospital initiatives and pilot programs to drive cost efficiencies and One Ramsay digital/AI synergies.
Ramsay Santé and Nordics Performance
Ramsay Santé delivered a 4.4% increase in underlying EBIT in constant currency, driven by strong Nordic performance (notably Sweden) and a new favourable contract at St. Göran.
Liquidity and Hedging Position
Consolidated net debt $5.1bn with adequate liquidity for the National Capital Hospital acquisition; ~65–67% of floating exposure hedged (average base rates ~3.0–3.65%), and Ramsay Santé has EUR 391m liquidity available.